
About Panjon
Panjon is a publicly listed company based in Indore (India) founded in 1964 by Nagin Kothari and Nagin Bhai Kothari. Ayurvedic formulations are manufactured and supplied by Panjon. The company has 6 employees. Its chief executive, as recorded, is Jay Kothari. Its Indian entity Panjon Limited reported revenue of βΉ47.92 Cr. Panjon offers products and services including PANJON Balm and Swad Digestive Drops. Its focus areas include Alternative Medicine Products.
Company details
Panjon was established in 1964 in Indore, India, as a manufacturer and supplier within the ayurvedic sector. Formulations based on traditional Indian medicine are produced and distributed from this location. Operations center on healthcare products, with oversight by CEO and MD Jay Kothari, alongside founders Nagin Kothari and Nagin Bhai Kothari. The domain panjon.in supports business activities.
- Market Cap₹29.73 Cr
PANJON · BSE
- Share Price₹18.00
+3.93% today
- Revenue₹12.26 Cr
FY 2015-16 · -37.1% YoY
- EBITDA−₹0.26 Cr
Margin -2.1%
- Net Profit₹0.37 Cr
FY 2015-16 · +110.8% YoY
- P/E (TTM)53.8x
P/B 1.8x
- ROE1.8%
ROCE 0.1%
- Debt / Equity0.09
Interest cover 0.0x
- Employee Count6
Associated legal entities of Panjon
Panjon operates through Panjon Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Panjon Limited Listed CIN L24232MP1983PLC002320 | Active | 23 Dec 1983 | Indore, Madhya Pradesh | ₹47.9 Cr | 6 | 7 | View details |
Products & Services of Panjon
Panjon offers a comprehensive portfolio of products and services, including PANJON Balm and Swad Digestive Drops.
A balm is provided for relief from ailments as part of the FMCG offerings.
Digestive drops are offered to support health needs within the product range.
Board of directors of Panjon Limited (Panjon)
Panjon Limited is the primary company behind Panjon. The board of Panjon Limited currently have 5 directors; the longest-serving is Jay Kothari, appointed in 2015. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jay Kothari DIN 00572543 | Managing Director | 03 Sep 2015 | 11 yrs 2 mo | Panjon Limited |
| Pooja Vishal Bhandari DIN 07867093 | Director | 27 Sep 2017 | 9 yrs 1 mo | Panjon Limited |
| Anju Kothari DIN 00567422 | Director | 14 Feb 2019 | 7 yrs 9 mo | Panjon Limited |
| Athak Mahajan DIN 10292097 | Director | 31 Aug 2023 | 3 yrs 2 mo | Panjon Limited |
| Rajiv Kumar DIN 10292119 | Director | 31 Aug 2023 | 3 yrs 2 mo | Panjon Limited |
People of Panjon
3 people are tracked at Panjon (3 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
Nagin Bhai Kothari | Founder | Leadership |
| CEO & MD | Leadership |
Complete people profiles for Panjon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Panjon
Panjon is a publicly listed company on the BSE with ticker symbol PANJON in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Feb 1994
- Listed onBSE: 526345
- Listed entityPanjon Ltd
- Exchange sectorHealth technology
- ISININE744D01019
- Share price₹20.40 (+2.26% on the day) · 2026-10-14
- Volume (last session)152
Financials of Panjon
Exchange-reported figures of Panjon Limited, the listed company behind Panjon (BSE: PANJON).
Financial Highlights
FY 2015-16 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Income statement | ||
| Revenue | 12.26 | 19.48 |
| Revenue growth | -37.1% | - |
| EBITDA | (0.26) | (4.62) |
| EBITDA margin | -2.1% | -23.7% |
| Profit before tax | 0.03 | (4.71) |
| Net profit | 0.37 | (3.43) |
| Net profit margin | +3.0% | -17.6% |
| EPS (βΉ) | 0.23 | 0.00 |
| Balance sheet | ||
| Total assets | 17.80 | 17.55 |
| Net worth | 16.39 | 16.02 |
| Total debt | 1.41 | 1.52 |
| Cash & bank | 0.25 | 0.70 |
| Net working capital | 14.84 | 14.85 |
| Cash flow | ||
| Cash from operations | (0.20) | 0.89 |
| Cash from investing | (0.06) | 4.74 |
| Cash from financing | (0.19) | (5.14) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 47.62 | 30.46 | 12.55 | 6.09 | 8.43 | 14.54 | 26.43 |
| Revenue growth | +56.3% | +142.7% | +106.1% | -27.8% | -42.0% | -45.0% | - |
| EBITDA | 0.98 | 0.64 | (0.01) | (0.01) | (4.05) | 0.19 | 0.33 |
| EBITDA margin | +2.1% | +2.1% | -0.1% | -0.2% | -48.0% | +1.3% | +1.3% |
| Profit before tax | 0.71 | 0.54 | 0.16 | 0.11 | (4.02) | 0.19 | 0.20 |
| Net profit | 0.60 | 0.41 | 0.16 | 0.80 | (4.16) | 0.10 | (0.02) |
| Net profit margin | +1.3% | +1.4% | +1.3% | +13.1% | -49.4% | +0.7% | -0.1% |
| EPS (βΉ) | 0.04 | 0.23 | 0.09 | 0.52 | (2.68) | 0.06 | (0.02) |
| Balance sheet | |||||||
| Total assets | - | 19.19 | 16.29 | 14.26 | 13.47 | 18.14 | 18.28 |
| Net worth | - | 16.55 | 14.85 | 13.48 | 12.66 | 16.81 | 16.73 |
| Total debt | - | 2.65 | 1.44 | 0.78 | 0.81 | 1.33 | 1.56 |
| Cash & bank | - | 0.44 | 2.72 | 1.47 | 1.44 | 0.31 | 0.28 |
| Net working capital | - | 11.80 | 11.45 | 10.01 | 8.35 | 10.93 | 10.56 |
| Cash flow | |||||||
| Cash from operations | - | (4.34) | (0.42) | 0.04 | 1.82 | 0.34 | 0.35 |
| Cash from investing | - | (0.44) | (0.21) | (0.19) | (0.19) | (0.06) | (0.51) |
| Cash from financing | - | 2.50 | 1.88 | 0.18 | (0.51) | (0.24) | (0.07) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.02 | 8.07 | 12.12 | 14.14 | 14.95 | 6.42 | 13.83 | 11.16 |
| Revenue growth (YoY) | -26.3% | +25.7% | -12.4% | +26.7% | +342.3% | +207.2% | - | - |
| Other income | 0.07 | 0.07 | 0.17 | 0.04 | 0.05 | 0.04 | 0.05 | 0.08 |
| Total expenses | 10.76 | 7.89 | 11.87 | 13.86 | 14.68 | 6.22 | 13.52 | 10.93 |
| EBITDA | 0.26 | 0.18 | 0.25 | 0.28 | 0.27 | 0.20 | 0.31 | 0.23 |
| EBITDA margin | +2.4% | +2.2% | +2.1% | +2.0% | +1.8% | +3.1% | +2.2% | +2.1% |
| Depreciation | 0.08 | 0.08 | 0.14 | 0.04 | 0.04 | 0.08 | 0.08 | 0.05 |
| Interest | 0.09 | 0.08 | 0.10 | 0.07 | 0.04 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 0.16 | 0.09 | 0.18 | 0.21 | 0.24 | 0.10 | 0.22 | 0.20 |
| Tax | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Revenue | 12.26 | 19.48 |
| Revenue growth | -37.1% | - |
| Other income | 0.43 | 0.04 |
| Total expenses | 12.52 | 24.10 |
| Employee cost | 0.37 | 0.24 |
| EBITDA | (0.26) | (4.62) |
| EBITDA margin | -2.1% | -23.7% |
| Depreciation | 0.14 | 0.13 |
| Interest | 0.00 | 0.00 |
| Profit before tax | 0.03 | (4.71) |
| Tax | (0.34) | (1.28) |
| Net profit | 0.37 | (3.43) |
| Net profit margin | +3.0% | -17.6% |
| EPS (βΉ) | 0.23 | 0.00 |
| Particulars | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Equity & liabilities | ||
| Share capital | 15.50 | 15.50 |
| Reserves & surplus | 0.89 | 0.52 |
| Shareholders' funds (net worth) | 16.39 | 16.02 |
| Minority interest | 0.00 | 0.00 |
| Secured loans | 1.23 | 1.42 |
| Unsecured loans | 0.18 | 0.10 |
| Total debt | 1.41 | 1.52 |
| Total liabilities | 17.80 | 17.55 |
| Assets | ||
| Gross block | 6.64 | 6.59 |
| Net block | 0.83 | 0.92 |
| Capital work in progress | 0.00 | 0.00 |
| Investments | 1.09 | 1.08 |
| Inventories | 2.94 | 2.50 |
| Sundry debtors | 8.78 | 9.83 |
| Cash & bank balances | 0.25 | 0.70 |
| Loans & advances | 3.12 | 2.33 |
| Total current assets | 15.09 | 15.36 |
| Total current liabilities | 0.25 | 0.51 |
| Net working capital | 14.84 | 14.85 |
| Total assets | 17.80 | 17.55 |
| Particulars | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Opening cash | 0.70 | 0.21 |
| Net cash from operating activities | (0.20) | 0.89 |
| Net cash from investing activities | (0.06) | 4.74 |
| Net cash from financing activities | (0.19) | (5.14) |
| Net change in cash | (0.44) | 0.49 |
| Closing cash | 0.25 | 0.70 |
| Particulars | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Growth | ||
| Sales growth | -37.1% | - |
| EBITDA growth | +94.4% | - |
| PBT growth | +9998.0% | +9997.0% |
| Net income growth | +110.8% | - |
| Profitability & leverage | ||
| Net income margin | +3.0% | -17.6% |
| Return on capital employed | +0.1% | 0.0% |
| Return on net worth | +1.8% | 0.0% |
| Debt / equity | 0.09 | 0.09 |
| Long-term debt / equity | 0.08 | 0.09 |
| Interest cover | 0.00 | 0.00 |
| Efficiency & per share | ||
| Fixed asset turnover | 1.85 | 2.96 |
| Inventory turnover | 4.51 | 7.79 |
| Debtors turnover | 1.32 | 1.98 |
| EPS (βΉ) | 0.23 | 0.00 |
| Dividend per share (βΉ) | 0.00 | 0.00 |
| Book value per share (βΉ) | 10.57 | 10.34 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.02 | 8.07 | 12.12 | 14.14 | 14.95 | 6.42 | 13.83 | 11.16 |
| Revenue growth (YoY) | -26.3% | +25.7% | -12.4% | +26.7% | +342.3% | +207.2% | - | - |
| Other income | 0.07 | 0.07 | 0.17 | 0.04 | 0.05 | 0.04 | 0.05 | 0.08 |
| Total expenses | 10.76 | 7.89 | 11.87 | 13.86 | 14.68 | 6.22 | 13.52 | 10.93 |
| EBITDA | 0.26 | 0.18 | 0.25 | 0.28 | 0.27 | 0.20 | 0.31 | 0.23 |
| EBITDA margin | +2.4% | +2.2% | +2.1% | +2.0% | +1.8% | +3.1% | +2.2% | +2.1% |
| Depreciation | 0.08 | 0.08 | 0.14 | 0.04 | 0.04 | 0.08 | 0.08 | 0.05 |
| Interest | 0.09 | 0.08 | 0.10 | 0.07 | 0.04 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 0.16 | 0.09 | 0.18 | 0.21 | 0.24 | 0.10 | 0.22 | 0.20 |
| Tax | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 47.62 | 30.46 | 12.55 | 6.09 | 8.43 | 14.54 | 26.43 |
| Revenue growth | +56.3% | +142.7% | +106.1% | -27.8% | -42.0% | -45.0% | - |
| Other income | 0.30 | 0.31 | 0.45 | 0.38 | 0.30 | 0.33 | 0.29 |
| Total expenses | 46.64 | 29.82 | 12.56 | 6.10 | 12.48 | 14.35 | 26.10 |
| Employee cost | 0.00 | 0.70 | 0.60 | 0.47 | 0.46 | 0.42 | 0.47 |
| EBITDA | 0.98 | 0.64 | (0.01) | (0.01) | (4.05) | 0.19 | 0.33 |
| EBITDA margin | +2.1% | +2.1% | -0.1% | -0.2% | -48.0% | +1.3% | +1.3% |
| Depreciation | 0.30 | 0.23 | 0.22 | 0.21 | 0.20 | 0.23 | 0.27 |
| Interest | 0.27 | 0.18 | 0.06 | 0.05 | 0.07 | 0.10 | 0.15 |
| Profit before tax | 0.71 | 0.54 | 0.16 | 0.11 | (4.02) | 0.19 | 0.20 |
| Tax | 0.11 | 0.13 | 0.00 | (0.69) | 0.14 | 0.09 | 0.22 |
| Net profit | 0.60 | 0.41 | 0.16 | 0.80 | (4.16) | 0.10 | (0.02) |
| Net profit margin | +1.3% | +1.4% | +1.3% | +13.1% | -49.4% | +0.7% | -0.1% |
| EPS (βΉ) | 0.04 | 0.23 | 0.09 | 0.52 | (2.68) | 0.06 | (0.02) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 17.17 | 16.31 | 15.50 | 15.50 | 15.50 | 15.50 |
| Reserves & surplus | - | (0.62) | (1.46) | (2.02) | (2.84) | 1.31 | 1.23 |
| Shareholders' funds (net worth) | - | 16.55 | 14.85 | 13.48 | 12.66 | 16.81 | 16.73 |
| Secured loans | - | 2.56 | 1.31 | 0.28 | 0.81 | 0.86 | 0.89 |
| Unsecured loans | - | 0.09 | 0.13 | 0.50 | 0.00 | 0.47 | 0.67 |
| Total debt | - | 2.65 | 1.44 | 0.78 | 0.81 | 1.33 | 1.56 |
| Total liabilities | - | 19.19 | 16.29 | 14.26 | 13.47 | 18.14 | 18.28 |
| Assets | |||||||
| Gross block | - | 8.46 | 8.04 | 7.83 | 7.84 | 7.66 | 7.59 |
| Net block | - | 1.09 | 0.90 | 0.91 | 0.94 | 0.97 | 1.12 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 1.10 | 1.08 | 1.08 | 1.07 | 1.07 | 1.08 |
| Inventories | - | 4.62 | 3.74 | 3.48 | 3.77 | 3.87 | 3.81 |
| Sundry debtors | - | 3.26 | 1.81 | 1.56 | 0.61 | 3.71 | 3.30 |
| Cash & bank balances | - | 0.44 | 2.72 | 1.47 | 1.44 | 0.31 | 0.28 |
| Loans & advances | - | 4.34 | 4.29 | 4.14 | 3.11 | 4.16 | 4.10 |
| Total current assets | - | 12.66 | 12.56 | 10.65 | 8.93 | 12.05 | 11.49 |
| Total current liabilities | - | 0.86 | 1.11 | 0.64 | 0.58 | 1.12 | 0.93 |
| Net working capital | - | 11.80 | 11.45 | 10.01 | 8.35 | 10.93 | 10.56 |
| Total assets | - | 19.19 | 16.29 | 14.26 | 13.47 | 18.14 | 18.28 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 2.72 | 1.47 | 1.44 | 0.31 | 0.28 | 0.50 |
| Net cash from operating activities | - | (4.34) | (0.42) | 0.04 | 1.82 | 0.34 | 0.35 |
| Net cash from investing activities | - | (0.44) | (0.21) | (0.19) | (0.19) | (0.06) | (0.51) |
| Net cash from financing activities | - | 2.50 | 1.88 | 0.18 | (0.51) | (0.24) | (0.07) |
| Net change in cash | - | (2.27) | 1.25 | 0.04 | 1.12 | 0.04 | (0.22) |
| Closing cash | - | 0.44 | 2.72 | 1.47 | 1.44 | 0.31 | 0.28 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +56.3% | +142.7% | +106.1% | -27.8% | -42.0% | -45.0% | - |
| EBITDA growth | +53.1% | +6500.0% | 0.0% | +99.8% | -2231.6% | -42.4% | - |
| PBT growth | +31.5% | +237.5% | +45.5% | +9998.0% | - | -5.0% | -31.0% |
| Net income growth | +46.3% | +156.3% | -80.0% | +119.2% | -4260.0% | +600.0% | - |
| Revenue CAGR (3Y) | +98.5% | +53.5% | -4.8% | -38.7% | -31.3% | -10.2% | +23.7% |
| EBITDA CAGR (3Y) | - | - | - | - | - | -23.2% | - |
| Profitability & leverage | |||||||
| Net income margin | +1.3% | +1.4% | +1.3% | +13.1% | -49.4% | +0.7% | -0.1% |
| Return on capital employed | - | +2.6% | +0.9% | +0.9% | 0.0% | +1.4% | 0.0% |
| Return on net worth | - | +1.6% | +0.6% | +4.4% | 0.0% | +0.5% | 0.0% |
| Debt / equity | - | 0.13 | 0.08 | 0.06 | 0.07 | 0.09 | 0.10 |
| Long-term debt / equity | - | 0.01 | 0.01 | -1.90 | 0.05 | 0.07 | 0.08 |
| Interest cover | 39.71 | 43.90 | -26.09 | -22.73 | -1.65 | -250.00 | 250.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 3.69 | 1.58 | 0.78 | 1.09 | 1.91 | 3.61 |
| Inventory turnover | - | 7.29 | 3.48 | 1.68 | 2.21 | 3.79 | 7.11 |
| Debtors turnover | - | 12.02 | 7.45 | 5.61 | 3.90 | 4.15 | 10.61 |
| EPS (βΉ) | 0.04 | 0.23 | 0.09 | 0.52 | (2.68) | 0.06 | (0.02) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 9.64 | 9.11 | 8.70 | 8.17 | 10.85 | 10.79 |
Web traffic of Panjon
The website of Panjon (panjon.in) receives about 2K visits a month.
- Monthly visits2K
▲ 37.6% vs previous month
Websites whose visitors overlap most with Panjon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
static.icmwebserv.com | static.icmwebserv.com | 100% | β | ||
| google.co.in | 100% | 77M | #407 | View details | |
| facebook.com | 100% | 12.1B | #3 | View details |
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as Panjon (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Panjon
Complete news archive for Panjon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Panjon
Panjon was founded in 1964.
Panjon is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Jay Kothari is the CEO of Panjon, as recorded in our data.
Panjon has 6 employees.
The primary company behind Panjon, Panjon Limited, reported revenue of βΉ47.92 Cr for FY 2026, up 56% year on year.
Panjon was established in 1964 in Indore, India, as a manufacturer and supplier within the ayurvedic sector. Formulations based on traditional Indian medicine are produced and distributed from this location. Operations center on healthcare products, with oversight by CEO and MD Jay Kothari, alongside founders Nagin Kothari and Nagin Bhai Kothari. The domain panjon.in supports business activities.
Panjon offers PANJON Balm and Swad Digestive Drops.
Yes, Panjon is publicly traded on BSE under the ticker symbol PANJON.
Panjon operates through Panjon Limited.
The legal entities of Panjon currently have 7 directors, including Pooja Vishal Bhandari, Jay Kothari, Anju Kothari and others.
